Product Information

LOESTRIN FE 1.5-30 TABLET is a brand (anda) product labeled by Teva Women's Health LLC, priced at $3.3310 per EA under NDC 51285012870. Its NADAC has been published 40 times since Apr 15, 2015.

FDA first approved this application on Sep 18, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for LOESTRIN FE 1.5-30 TABLET has been published 40 times since Apr 15, 2015, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.